×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 3: Turning fundamental research into innovative treatments
Session Chair(s)
Greg Jordinson, MSc
Associate Director, EMEA Policy Lead, Global Regulatory Policy and Intelligence
Janssen R&D, United Kingdom
Session 3: Turning fundamental research into innovative treatments
Speaker(s)
“The Value of the Innovation” – PhRMA Report
Greg Jordinson, MSc
Janssen R&D, United Kingdom
Associate Director, EMEA Policy Lead, Global Regulatory Policy and Intelligence
Patients Driving Innovation
Mathieu Boudes, PhD
Montsouris Consilium, France
Patient Engagement Director
The use of Real World Data in Regulatory Decision
Gracy G Crane, PhD, MS
Roche, United Kingdom
Policy Lead
Have an account?